PMID- 12919125 OWN - NLM STAT- MEDLINE DCOM- 20031021 LR - 20191107 IS - 1396-0296 (Print) IS - 1396-0296 (Linking) VI - 16 IP - 1 DP - 2003 TI - Diagnosis and treatment of actinic prurigo. PG - 40-4 AB - Actinic prurigo (AP) is an idiopathic photodermatosis that affects mainly the mestizo population in Latin America. It has an early onset, a slight predominance in women, and affects the sun-exposed areas of the skin, causing erythematous papules and lichenified plaques secondary to intense and chronic pruritus. Lesions can be induced by both ultraviolet A (UVA) and ultraviolet B (UVB). An association with several human leukocyte antigen (HLA) alleles has been reported. AP is unique among all photodermatoses in its remarkable response to thalidomide. In the past the microscopic features of AP have been considered as nonspecific; however, the constant finding of dense lymphocytic inflammatory infiltrates and the immunogenetic features of AP support the existence of an immunologic mechanism in its pathogenesis. FAU - Hojyo-Tomoka, Maria-Teresa AU - Hojyo-Tomoka MT AD - Department of Dermatology, Hospital General "Dr. Manuel Gea Gonzalez," Mexico City, Mexico. dermagea@prodigy.net.mx FAU - Vega-Memije, Maria-Elisa AU - Vega-Memije ME FAU - Cortes-Franco, Roberto AU - Cortes-Franco R FAU - Dominguez-Soto, Luciano AU - Dominguez-Soto L LA - eng PT - Journal Article PT - Review PL - United States TA - Dermatol Ther JT - Dermatologic therapy JID - 9700070 RN - 0 (Dermatologic Agents) RN - 4Z8R6ORS6L (Thalidomide) SB - IM MH - Dermatologic Agents/therapeutic use MH - Diagnosis, Differential MH - Humans MH - Photosensitivity Disorders/*diagnosis/drug therapy/immunology MH - Prurigo/*diagnosis/drug therapy/immunology MH - Thalidomide/therapeutic use RF - 16 EDAT- 2003/08/16 05:00 MHDA- 2003/10/22 05:00 CRDT- 2003/08/16 05:00 PHST- 2003/08/16 05:00 [pubmed] PHST- 2003/10/22 05:00 [medline] PHST- 2003/08/16 05:00 [entrez] AID - 01606 [pii] AID - 10.1046/j.1529-8019.2003.01606.x [doi] PST - ppublish SO - Dermatol Ther. 2003;16(1):40-4. doi: 10.1046/j.1529-8019.2003.01606.x.